NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85 | +10.4% | 11,807 | +14.6% | 0.00% | 0.0% |
| Q2 2023 | $77 | +8.5% | 10,307 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $71 | -40.3% | 10,307 | -10.9% | 0.00% | -42.9% |
| Q4 2022 | $119 | -99.9% | 11,562 | +2.5% | 0.01% | -41.7% |
| Q3 2022 | $205,000 | -63.7% | 11,282 | +3.0% | 0.01% | -61.3% |
| Q2 2022 | $564,000 | -15.1% | 10,957 | +21.5% | 0.03% | +3.3% |
| Q1 2022 | $664,000 | -13.0% | 9,017 | +69.0% | 0.03% | -9.1% |
| Q4 2021 | $763,000 | -15.8% | 5,336 | +22.1% | 0.03% | -23.3% |
| Q3 2021 | $906,000 | +14.5% | 4,369 | +17.3% | 0.04% | +16.2% |
| Q2 2021 | $791,000 | +20.4% | 3,724 | +2.8% | 0.04% | +2.8% |
| Q1 2021 | $657,000 | +34.9% | 3,624 | -17.0% | 0.04% | -16.3% |
| Q4 2020 | $487,000 | +28.8% | 4,365 | +25.1% | 0.04% | +19.4% |
| Q3 2020 | $378,000 | -3.3% | 3,489 | -25.6% | 0.04% | -2.7% |
| Q2 2020 | $391,000 | – | 4,692 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |